Cargando…

FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging

One of the key research agenda of the field of aging is investigation of presymptomatic Alzheimer’s disease (AD). Furthermore, abnormalities in brain glucose metabolism (as measured by FDG-PET) have been reported among cognitively normal elderly persons. However, little is known about the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krell-Roesch, Janina, Ruider, Hanna, Lowe, Val J., Stokin, Gorazd B., Pink, Anna, Roberts, Rosebud O., Mielke, Michelle M., Knopman, David S., Christianson, Teresa J., Machulda, Mary M., Jack, Clifford R., Petersen, Ronald C., Geda, Yonas E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981903/ https://www.ncbi.nlm.nih.gov/pubmed/27447426 http://dx.doi.org/10.3233/JAD-160326

Ejemplares similares

Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging
por: Krell-Roesch, Janina, et al.
Publicado: (2019)

Neuropsychiatric symptoms and the outcome of cognitive trajectories in older adults free of dementia: The Mayo Clinic Study of Aging
por: Krell‐Roesch, Janina, et al.
Publicado: (2021)

Leisure-Time Physical Activity and the Risk of Incident Dementia: The Mayo Clinic Study of Aging
por: Krell-Roesch, Janina, et al.
Publicado: (2018)

Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline
por: Pink, Anna, et al.
Publicado: (2023)

A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment
por: Pink, Anna, et al.
Publicado: (2021)

Mild Neurocognitive Disorder: An Old Wine in a New Bottle
por: Stokin, Gorazd B., et al.
Publicado: (2015)

Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging
por: Krell-Roesch, Janina, et al.
Publicado: (2021)

Association of non-exercise physical activity in mid- and late-life with cognitive trajectories and the impact of APOE ε4 genotype status: the Mayo Clinic Study of Aging
por: Krell-Roesch, Janina, et al.
Publicado: (2019)

Quantity and quality of mental activities and the risk of incident mild cognitive impairment
por: Krell-Roesch, Janina, et al.
Publicado: (2019)

Plasma‐derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community‐based study
por: Krell‐Roesch, Janina, et al.
Publicado: (2023)

Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment
por: Vassilaki, Maria, et al.
Publicado: (2023)

Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Brain amyloid, cortical thickness, and changes in activities of daily living
por: Vassilaki, Maria, et al.
Publicado: (2020)

Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease
por: Alden, Eva C., et al.
Publicado: (2022)

Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults
por: Arenaza-Urquijo, Eider M., et al.
Publicado: (2020)

Cortical atrophy patterns of incident MCI subtypes in the Mayo Clinic Study of Aging
por: Machulda, Mary M., et al.
Publicado: (2020)

(1)H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults
por: Nedelska, Zuzana, et al.
Publicado: (2017)

Untreated Type 2 Diabetes and Its Complications Are Associated With Subcortical Infarctions
por: Roberts, Rosebud O., et al.
Publicado: (2011)

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
por: Jack, Clifford R., et al.
Publicado: (2015)

Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele
por: Roberts, Rosebud O., et al.
Publicado: (2015)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

White matter changes in empirically derived incident MCI subtypes in the Mayo Clinic Study of Aging
por: Machulda, Mary M., et al.
Publicado: (2021)

Posterior cortical atrophy phenotypic heterogeneity revealed by decoding (18)F-FDG-PET
por: Townley, Ryan A, et al.
Publicado: (2021)

NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages
por: Petersen, Ronald C., et al.
Publicado: (2021)

Association between physical activity and longitudinal change in body mass index in middle-aged and older adults
por: Cleven, Laura, et al.
Publicado: (2023)

(18)F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus
por: Townley, Ryan A., et al.
Publicado: (2018)

Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study
por: Jack, Clifford R., et al.
Publicado: (2017)

Rates of transition between amyloid and neurodegeneration biomarker states and to dementia among non-demented individuals: a population-based cohort study
por: Jack, Clifford R., et al.
Publicado: (2015)

Investigating cognition in midlife
por: Novotný, Jan S., et al.
Publicado: (2021)

Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
por: Singh, Tarun D., et al.
Publicado: (2015)

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
por: Vemuri, Prashanthi, et al.
Publicado: (2015)

FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer’s Type
por: Madhavan, Ajay, et al.
Publicado: (2013)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Acceptance and Commitment Therapy in a Low-Income Country in Sub-Saharan Africa: A Call for Further Research
por: Geda, Yonas E., et al.
Publicado: (2021)

Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging
por: Vemuri, Prashanthi, et al.
Publicado: (2019)

Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework
por: Jack, Clifford R., et al.
Publicado: (2019)

Longitudinal deterioration of white-matter integrity: heterogeneity in the ageing population
por: Poulakis, Konstantinos, et al.
Publicado: (2021)

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes
por: Marks, Jordan D., et al.
Publicado: (2021)

White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline
por: Vemuri, Prashanthi, et al.
Publicado: (2021)

Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample
por: Jung, Youngsin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9oravqtasoedo4afkocmmdi05r